Skip to main content
. 2016 Jan 21;21:773–782. doi: 10.1007/s10147-016-0952-6

Fig. 2.

Fig. 2

Comparison of individual enzalutamide Cmax and AUC during single-dosing. aPhase I, open-label, dose-escalation safety and pharmacokinetic study of enzalutamide in patients with CRPC conducted overseas [19]